News Archives - QualityStocks

TuesdayMar 31, 2026 11:15 am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

LIXTE’s lead compound, LB-100, is the world’s first and only clinical-stage inhibitor of protein phosphatase 2A (“PP2A”). LB-100 helps in the fight against cancer in a few ways, as it makes cancer cells more sensitive to immunotherapy and chemotherapy, while also disrupting cancer’s internal repair system. The compound has demonstrated a favorable safety profile in Phase 1 clinical trials and has been supported by over 25 published preclinical and translational studies so far. LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100.…

TuesdayMar 31, 2026 10:30 am

GPS-Denied Navigation Isn’t Just a Problem for the Future, It’s Happening Right Now

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. GPS jamming has emerged as a key modern warfare tactic, using high-powered radio signals to disrupt satellite navigation and shape both offensive operations and defensive countermeasures on the battlefield. This sparks major concern for many organizations and military forces, as several aspects of war rely on GPS, such as tracking, navigation, communication, and others. To fight back against GPS jamming, companies like SPARC AI have created GPS-free technology to deliver real-time insights, detection, and tracking, without having to rely on radar, lidar, and sensors.…

TuesdayMar 31, 2026 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Expands Pipeline Momentum as SGX945 Earns Global Recognition

In the life sciences industry, a robust pipeline is widely recognized as a critical driver of value creation and sustainability. The significance of the UK designation extends beyond a single program. The UK designation builds on additional regulatory recognition for dusquetide, including orphan drug designation from the FDA for Behçet’s disease. A strong and diversified pipeline is often the foundation of long-term success in the biotechnology sector, enabling companies to sustain innovation while advancing multiple therapeutic opportunities. Soligenix (NASDAQ: SNGX) is reinforcing that foundation as its investigational therapy SGX945 receives Promising Innovative Medicine designation in the United Kingdom, a development…

TuesdayMar 31, 2026 9:00 am

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Is ‘One to Watch’

Cardiovascular disease remains the leading cause of death in the United States, representing a significant and persistent healthcare burden that the company’s solutions are designed to address. Cardio Diagnostics has developed a proprietary platform that integrates epigenetic and genetic biomarkers with artificial intelligence to generate personalized cardiovascular insights from a simple blood sample. The company’s clinical tests are non-invasive, require no fasting or radiation, and are designed to detect and assess coronary heart disease, including forms that may not be identified through traditional diagnostic methods. The company has established multiple commercialization channels, including provider networks, employer partnerships, and community-based programs,…

MondayMar 30, 2026 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Seen as an Easy Way to Capitalize on Gold’s Rare Affordable Price

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, continues to demonstrate why gold is a viable investment in 2026. Despite the high volatility of gold and silver over the past year, the ongoing rise of worldwide debt, and its effect on currency and inflation, is expected to continue as a fundamental driver for such tangible assets. The active mining of gold represents both a productive business operation and a high-value end product, a buffer to volatility…

MondayMar 30, 2026 10:30 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Rare Earth Projects Represent Enhanced Strategic Value Amid Iran Conflict

Disseminated on behalf of  Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. The conflict involving Iran, with associated tensions between Washington and Beijing, are increasing scrutiny of critical mineral supply chains, particularly rare earth elements (“REEs”). China controls roughly 90% of the world’s processed rare earth supply, giving Beijing significant leverage over global technology and defense manufacturing. Beijing has expanded export controls on several rare earth elements and related technologies, reinforcing its dominance in the supply chain. Western governments are accelerating efforts to build alternative supply sources in North America, with funding and procurement programs emerging…

MondayMar 30, 2026 9:45 am

Forward Industries Inc. (NASDAQ: FWDI) and the Cryptocurrency Market Represent a Rare Opportunity for Investors

2026 has been a volatile period in the crypto market, but the current state of the industry serves as a unique and unexpected opportunity to invest in something that was much more expensive only a short time ago. While periodic ups and downs are to be expected, due to outside factors, all of the long-term forces supporting the move to blockchain and digital currencies remain in play. This applies to Solana (SOL), thanks to its high speed, low transaction cost, and high transaction volume, and to Forward Industries Inc., the largest SOL treasury and an easy way to enter the…

MondayMar 30, 2026 9:00 am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded LB-100 Clinical Trials

Researchers are increasingly focused on combination therapies and novel mechanisms of action that can enhance tumor response to treatment. LIXTE’s LB-100 is designed to sensitize cancer cells to chemotherapy and potentially enhance immune system activity, offering a complementary approach to existing treatments. The company recently announced the expansion of its ongoing clinical trial in clear cell ovarian cancer, including an increase in patient enrollment that effectively doubles the size of the study. Ovarian clear cell carcinoma and metastatic colon cancer remain among the most challenging malignancies to treat, with limited effective therapies and poor patient outcomes driving the urgent need…

FridayMar 27, 2026 11:15 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Executives Outline Positive PEA Results Plus Company’s Next Steps to Production in Investor Webinar

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. Canadian near-term gold producer LaFleur Minerals recently released the results of a Preliminary Economic Assessment (“PEA”) outlining a capital efficient project with robust economic returns LaFleur executives Kal Malhi (Chairman) and Paul Ténière (CEO and Director) participated in a March 24 webinar where they discussed the positive PEA results with investors as well as outlining some of the company’s next steps LaFleur’s strategy is based on a low CapEx mine-to-mill project, which includes a wholly owned and permitted gold mill approaching restart readiness, a…

FridayMar 27, 2026 10:30 am

The Permitting Fog Is Lifting on One of North America’s Highest-Grade Copper Projects

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. Arctic deposit grades are approximately 5.6% copper equivalent, with a projected mine life of 13 years at planned throughput, placing it among the highest-grade undeveloped copper projects globally. The Trump administration has reinstated the 2020 record of decision for the Ambler Access Road in Alaska through a presidential decree, while the repeal of Public Land Order 5150 could remove approximately 25 miles of road from federal permitting jurisdiction entirely. The U.S. Department of War committed $35.6 million to the Upper Kobuk Mineral Projects…

Site Search

Company Search

Category: News